Therapeutic Agent Toxicity Completed Phase 2 Trials for Oxaliplatin (DB00526)

Also known as: Drug Toxicity / Toxicity, Drug / Toxicity / Drug intoxication / Drug poisoning / Poisoning by unspecified drug or medicinal substance / Drug toxicity NOS / Drug toxicity (NOS) / Poisoning by drug AND/OR medicinal substance (disorder) / Poisoning (disorder) / Toxic effect of unspecified substance, accidental (unintentional) / Poisoning / Poisoning NOS / Toxicity to various agents

IndicationStatusPhase
DBCOND0083667 (Therapeutic Agent Toxicity)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04425564Study of Metronomic Capecitabine and Oxaliplatin Versus XELOX in Egyptian Metastatic Colorectal Cancer PatientsOther
NCT02143219Efficacy and Tolerance Evaluation in FOLFIRINOX Dose Adjusted in Elderly Patients With a Metastatic Pancreatic CancerTreatment